TY - JOUR
T1 - Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus
AU - Eyal, Zohar
AU - Matzov, Donna
AU - Krupkin, Miri
AU - Wekselman, Itai
AU - Paukner, Susanne
AU - Zimmerman, Ella
AU - Rozenberg, Haim
AU - Bashan, Anat
AU - Yonath, Ada
PY - 2015/10/27
Y1 - 2015/10/27
N2 - The emergence of bacterial multidrug resistance to antibiotics threatens to cause regression to the preantibiotic era. Here we present the crystal structure of the large ribosomal subunit from Staphylococcus aureus, a versatile Gram-positive aggressive pathogen, and its complexes with the known antibiotics linezolid and telithromycin, as well as with a new, highly potent pleuromutilin derivative, BC-3205. These crystal structures shed light on specific structural motifs of the S. aureus ribosome and the binding modes of the aforementioned antibiotics. Moreover, by analyzing the ribosome structure and comparing it with those of nonpathogenic bacterial models, we identified some unique internal and peripheral structural motifs that may be potential candidates for improving known antibiotics and for use in the design of selective antibiotic drugs against S. aureus.
AB - The emergence of bacterial multidrug resistance to antibiotics threatens to cause regression to the preantibiotic era. Here we present the crystal structure of the large ribosomal subunit from Staphylococcus aureus, a versatile Gram-positive aggressive pathogen, and its complexes with the known antibiotics linezolid and telithromycin, as well as with a new, highly potent pleuromutilin derivative, BC-3205. These crystal structures shed light on specific structural motifs of the S. aureus ribosome and the binding modes of the aforementioned antibiotics. Moreover, by analyzing the ribosome structure and comparing it with those of nonpathogenic bacterial models, we identified some unique internal and peripheral structural motifs that may be potential candidates for improving known antibiotics and for use in the design of selective antibiotic drugs against S. aureus.
UR - http://www.scopus.com/inward/record.url?scp=84945559980&partnerID=8YFLogxK
U2 - 10.1073/pnas.1517952112
DO - 10.1073/pnas.1517952112
M3 - Article
SN - 0027-8424
VL - 112
SP - E5805-E5814
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 43
ER -